1 Tuberculosis Vaccines Market Overview
1.1 Product Overview and Scope of Tuberculosis Vaccines
1.2 Tuberculosis Vaccines Segment by Type
1.2.1 Global Tuberculosis Vaccines Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 Tuberculosis Vaccines Segment by Application
1.3.1 Global Tuberculosis Vaccines Sales Comparison by Application: (2023-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Tuberculosis Vaccines Market Size Estimates and Forecasts
1.4.1 Global Tuberculosis Vaccines Revenue 2017-2030
1.4.2 Global Tuberculosis Vaccines Sales 2017-2030
1.4.3 Tuberculosis Vaccines Market Size by Region: 2017 Versus 2022 Versus 2030
2 Tuberculosis Vaccines Market Competition by Manufacturers
2.1 Global Tuberculosis Vaccines Sales Market Share by Manufacturers (2017-2023)
2.2 Global Tuberculosis Vaccines Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Tuberculosis Vaccines Average Price by Manufacturers (2017-2023)
2.4 Manufacturers Tuberculosis Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Tuberculosis Vaccines Market Competitive Situation and Trends
2.5.1 Tuberculosis Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccines Players Market Share by Revenue
2.5.3 Global Tuberculosis Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Vaccines Retrospective Market Scenario by Region
3.1 Global Tuberculosis Vaccines Retrospective Market Scenario in Sales by Region: 2017-2023
3.2 Global Tuberculosis Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2023
3.3 North America Tuberculosis Vaccines Market Facts & Figures by Country
3.3.1 North America Tuberculosis Vaccines Sales by Country
3.3.2 North America Tuberculosis Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Tuberculosis Vaccines Market Facts & Figures by Country
3.4.1 Europe Tuberculosis Vaccines Sales by Country
3.4.2 Europe Tuberculosis Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Tuberculosis Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Tuberculosis Vaccines Sales by Region
3.5.2 Asia Pacific Tuberculosis Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Tuberculosis Vaccines Market Facts & Figures by Country
3.6.1 Latin America Tuberculosis Vaccines Sales by Country
3.6.2 Latin America Tuberculosis Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Tuberculosis Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Tuberculosis Vaccines Sales by Country
3.7.2 Middle East and Africa Tuberculosis Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Tuberculosis Vaccines Historic Market Analysis by Type
4.1 Global Tuberculosis Vaccines Sales Market Share by Type (2017-2023)
4.2 Global Tuberculosis Vaccines Revenue Market Share by Type (2017-2023)
4.3 Global Tuberculosis Vaccines Price by Type (2017-2023)
5 Global Tuberculosis Vaccines Historic Market Analysis by Application
5.1 Global Tuberculosis Vaccines Sales Market Share by Application (2017-2023)
5.2 Global Tuberculosis Vaccines Revenue Market Share by Application (2017-2023)
5.3 Global Tuberculosis Vaccines Price by Application (2017-2023)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.1.4 Sanofi Tuberculosis Vaccines Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Merck Tuberculosis Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Serum Institute of India
6.3.1 Serum Institute of India Corporation Information
6.3.2 Serum Institute of India Description and Business Overview
6.3.3 Serum Institute of India Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Serum Institute of India Tuberculosis Vaccines Product Portfolio
6.3.5 Serum Institute of India Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.4.4 GlaxoSmithKline Tuberculosis Vaccines Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 Japan BCG Lab
6.5.1 Japan BCG Lab Corporation Information
6.5.2 Japan BCG Lab Description and Business Overview
6.5.3 Japan BCG Lab Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Japan BCG Lab Tuberculosis Vaccines Product Portfolio
6.5.5 Japan BCG Lab Recent Developments/Updates
6.6 IDT Biologics
6.6.1 IDT Biologics Corporation Information
6.6.2 IDT Biologics Description and Business Overview
6.6.3 IDT Biologics Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.6.4 IDT Biologics Tuberculosis Vaccines Product Portfolio
6.6.5 IDT Biologics Recent Developments/Updates
6.7 GreenSignal Bio Pharma
6.6.1 GreenSignal Bio Pharma Corporation Information
6.6.2 GreenSignal Bio Pharma Description and Business Overview
6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.4.4 GreenSignal Bio Pharma Tuberculosis Vaccines Product Portfolio
6.7.5 GreenSignal Bio Pharma Recent Developments/Updates
6.8 Taj Pharmaceuticals
6.8.1 Taj Pharmaceuticals Corporation Information
6.8.2 Taj Pharmaceuticals Description and Business Overview
6.8.3 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Taj Pharmaceuticals Tuberculosis Vaccines Product Portfolio
6.8.5 Taj Pharmaceuticals Recent Developments/Updates
6.9 Bavarian Nordic
6.9.1 Bavarian Nordic Corporation Information
6.9.2 Bavarian Nordic Description and Business Overview
6.9.3 Bavarian Nordic Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Bavarian Nordic Tuberculosis Vaccines Product Portfolio
6.9.5 Bavarian Nordic Recent Developments/Updates
6.10 China National Biotec Group
6.10.1 China National Biotec Group Corporation Information
6.10.2 China National Biotec Group Description and Business Overview
6.10.3 China National Biotec Group Tuberculosis Vaccines Sales, Revenue and Gross Margin (2017-2023)
6.10.4 China National Biotec Group Tuberculosis Vaccines Product Portfolio
6.10.5 China National Biotec Group Recent Developments/Updates
7 Tuberculosis Vaccines Manufacturing Cost Analysis
7.1 Tuberculosis Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Tuberculosis Vaccines
7.4 Tuberculosis Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Tuberculosis Vaccines Distributors List
8.3 Tuberculosis Vaccines Customers
9 Tuberculosis Vaccines Market Dynamics
9.1 Tuberculosis Vaccines Industry Trends
9.2 Tuberculosis Vaccines Market Drivers
9.3 Tuberculosis Vaccines Market Challenges
9.4 Tuberculosis Vaccines Market Restraints
10 Global Market Forecast
10.1 Tuberculosis Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Tuberculosis Vaccines by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Tuberculosis Vaccines by Type (2023-2030)
10.2 Tuberculosis Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Tuberculosis Vaccines by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Tuberculosis Vaccines by Application (2023-2030)
10.3 Tuberculosis Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Tuberculosis Vaccines by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Tuberculosis Vaccines by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
